Revolution Medicines, Inc.·4

Mar 4, 7:03 PM ET

Cislini Jeff 4

4 · Revolution Medicines, Inc. · Filed Mar 4, 2025

Insider Transaction Report

Form 4
Period: 2025-03-01
Cislini Jeff
General Counsel
Transactions
  • Award

    Common Stock

    2025-03-01+22,00061,222 total
  • Award

    Stock Option (Right to Buy)

    2025-03-01+77,00077,000 total
    Exercise: $40.74Exp: 2035-02-28Common Stock (77,000 underlying)
Footnotes (2)
  • [F1]Includes 58,204 restricted stock units.
  • [F2]One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary